2022 - 48TH ANNUAL REMINGTON WINTER COURSE AGENDAStreaming video content (Vimeo) covers the sessions below
Sunday, February 6, 2022
12:00-1:50pm |
Registration and Visit Exhibits |
1:50-2:00pm |
Welcome Remarks |
2:00-2:30pm |
COVID: Vaccines and Immunity
~ Carlos del Rio, MD |
2:30-3:00pm |
Treatment: Where Are We with COVID-19
~ Paul G. Auwaerter, MD, MBA, FIDSA
|
3:00-3:30pm |
Post-COVID Conditions ~ Carlos del Rio, MD
|
3:30–3:45pm |
Break and Visit Exhibits |
3:45–4:15pm |
Looking at COVID-19: Lessons Learned that Inform Public Health Response – ~ Richard P. Wenzel, MD, MSc |
4:15-4:45pm |
HAI Prevention After the COVID-19 Pandemic: What Did We Learn? ~ Daniel J. Diekema, MD, D(ABMM), FACP |
4:45-5:15pm |
Key ASP Publications Published During COVID-19 ~ Debra Goff, PharmD, FIDSA, FCCP
|
MONDAY, February 7, 2022
7:00-7:30am |
Breakfast and Visit Exhibits |
7:30-8:00am |
Long-acting Antiretrovirals for Treatment and Prevention – From Clinical Trials to the Clinic
~ Wendy S. Armstrong, MD |
8:00-8:30am |
Implementing PEP and PrEP
~ Jeanne Marrazzo, MD, MPH, FACP, FIDSA |
8:30-8:45am
|
Break and Visit Exhibits
|
8:45-9:15am |
Addressing Non-communicable Diseases in Persons with HIV
~ Wendy S. Armstrong, MD
|
9:15-9:45am |
Treating Latent TB Infection in 2022
~ Charles L. Daley, MD |
9:45-10:00am |
Questions and Answers |
3:15-4:00pm |
Meet the Professors |
3:15-4:00pm |
Break and Visit Exhibits
|
4:00-4:30pm |
HCV Treatment Simplification
~ Susanna Naggie, MD
|
4:30-5:00pm |
What’s New in the Prevention and Treatment of Hepatitis B
~ Susanna Naggie, MD
|
5:00-6:30pm |
Cases
|
Tuesday, February 8, 2022
7:00-7:30am |
Breakfast and Visit Exhibits |
7:30-8:00am |
Update on Rapid Antimicrobial Susceptibility Testing
~ Robin Patel, MD |
8:00-8:30am |
Transplant ID Update
~ Kimberly E. Hanson, MD, MHS |
8:30-8:45am |
Break and Visit Exhibits
|
8:45-9:15am |
Diagnostic Stewardship Update
~ Robin Patel, MD
|
9:15-9:45am |
Can Gut Microbiota Manipulation Reduce Antibiotic Resistance?
~ Mary Hayden, MD |
9:45-10:15am |
Fever in the Returning Traveler
~ James H. Maguire, MD, MPH |
3:15-4:00pm |
Meet the Professors |
3:15-4:00pm |
Break and Visit Exhibits
|
4:00–4:30 pm |
Endemic Mycoses
~ Andrej Spec, MD, MSCIHC
|
4:30-5:00pm |
Invasive Mycoses Complicating Respiratory Viral Infections
~ Andrej Spec, MD, MSCI
|
5:00-6:30pm |
Cases
|
Wednesday, February 9, 2022
7:00-7:30am |
Breakfast and Visit Exhibits |
7:30-8:00am |
Gram-negative Antibiotics – What’s New?
~ Helen W. Boucher MD FACP FIDSA |
8:00-8:30am |
Recent Publications that Will Change your Practice
~ Sara E. Cosgrove, MD, MS |
8:30-8:45am |
Break and Visit Exhibits
|
8:45-9:15am |
FUO – What Have We Learned in 60 Years?
~ Paul G. Auwaerter, MD, MBA, FIDSA
|
9:15-9:45am |
Parasitic Diseases Endemic in North America
~ James H. Maguire, MD, MPH |
9:45-10:00am |
Questions and Answers |
3:15-4:00pm |
Meet the Professors |
3:15-4:00pm |
Break and Visit Exhibits
|
4:00-4:30pm |
Case-based Approach to MDR-GNR
~ Pranita D. Tamma, MD
|
4:30-5:00pm |
Clostridium difficile: New Approaches to Prevention and Treatment
~ Mary Hayden, MD
|
5:00-5:30pm |
STD Update and Resistance Issues
~ Jeanne Marrazzo, MD, MPH, FACP, FIDSA
|
5:30-6:30pm |
Cases
|
thursday, February 10, 2022
7:00-7:30am |
Breakfast and Visit Exhibits |
7:30-8:00am |
Mycobacterial Conundrums: A Guided Tour of Challenging Cases
~ Charles L. Daley, MD |
8:00-8:30am |
Bone and Joint Infections in Children
~ Pranita D. Tamma, MD |
8:30-9:00am |
How to Win Friends and Influence Antibiotic Use
~ Debra Goff, PharmD, FIDSA, FCCP
|
9:00-9:30am |
S aureus Bacteremia
~ Sara E. Cosgrove, MD, MS
|
9:30–10:00am |
Q&A and Adjourn |
Acknowledgement of Financial Commercial Support
- Gilead Sciences, Inc
- ViiV Healthcare
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. If you need MOC credit, you also need to pass a posttest with a score of at least 80%. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Winter Course in infectious disease. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this live activity / enduring material for a maximum of 21 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 21 knowledge-based CPE contact hours.
Nurses
Amedco LLC designates this activity for a maximum of 21 ANCC contact hours.
|